Plunkett Research Online: Keryx Biopharmaceuticals Inc

KERYX BIOPHARMACEUTICALS INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal diseases. Keryx’s product portfolio includes U.S. FDA-approved Auryxia (ferric citrate). Auryxia is an oral, iron-based .....


KERYX BIOPHARMACEUTICALS INC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617-466-3500
Fax: 617-466-3501
Address: One Marina Park Drive, Fl. 12
Boston, MA 02210 United States

Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Akebia Therapeutics Inc

ContactsDescription

Jodie MorrisonCEO/Director
Scott HolmesCFO/Chief Accounting Officer/Treasurer
See More
Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal diseases. Keryx’s product portfolio includes U.S. FDA-approved Auryxia (ferric citrate). Auryxia is an oral, iron-based .....See More See More

$USD, In whole numbers 2018201720162015201420132012
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture